Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook



The Fertility Show





Whole-genome sequencing may improve cancer diagnosis

03 May 2011

By Mehmet Fidanboylu

Appeared in BioNews 605

Two US studies have demonstrated how whole-genome screening can help improve cancer treatment and diagnosis. The researchers claim to have taken a major step towards using this type of screening to help predict patients' responses to different treatment based on their genetics.

In one of the studies, researchers from the University of Alabama sequenced the genome of a woman with leukaemia using cells taken from her skin and bone marrow. Within six weeks, the technique revealed genetic defects that would have remained undetected by conventional diagnostic tests.

This led to the patient's treatment plan being changed from bone marrow transplantation to a targeted chemotherapy regime. The treatment proved successful and the patient is now in remission.

The second study looked at a woman who had died of breast cancer and ovarian cancer after a relapse. By obtaining the patient's genomic sequence, the researchers discovered she had several previously-undetected genetic traits. Her children can now be screened to see if they have inherited these traits so they can take preventative measures, such as pre-emptive mastectomy, if necessary.

Professor Boris Pasche, deputy director at the Birmingham Comprehensive Cancer Centre at the University of Alabama, and one of the lead scientists in the studies, explained: 'If patients have certain genes, they may not respond to certain treatments. But whole-genome sequencing gives a full picture of the genetic make-up of the tumour and the patient, and it may allow the physician to target a new treatment'.

Following completion of the Human Genome Project in 2003, some people believed that unlocking the human genome could lead to new cures for many diseases and personalised treatments. However, although a useful tool in pre-clinical research, the cost of whole-genome sequencing has been largely prohibitive.

As the technique becomes automated and more widely used in research, the cost of whole-genome sequencing may fall until it becomes a viable method for cancer diagnosis.

'Prices are still dropping very rapidly; in the next 10 years, it will cost less than US $10,000, and it certainly will be more affordable in the next five years', said Professor Pasche. He added: 'These cases of personalised genomic medicine are just some of the first examples of what will likely be commonplace in the near future'.

The studies were published in the Journal of the American Medical Association (JAMA).

 

SOURCES & REFERENCES
Mirror | 20 April 2011
 
Expert predicts cancer advances
Press Association | 20 April 2011
 
Journal of the American Medical Association (JAMA) | 20 April 2011
 
Journal of the American Medical Association (JAMA) | 20 April 2011
 
Journal of the American Medical Association (JAMA) | 20 April 2011
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

10 December 2012 - by Antony Blackburn-Starza 
The UK Government has announced plans that will allow 100,000 NHS patients to have their whole genome sequenced over the next three to five years, as part of a move to boost economic growth in the life sciences industry... [Read More]
08 October 2012 - by Paola Quattroni 
A computer-based platform which looks to greatly speed up genetic analysis of tumours has been unveiled in the USA. Currently such analysis can take up to eight weeks, the new platform promises to deliver results in just 47 seconds... [Read More]
08 May 2012 - by Sarah Norcross and Sandy Starr 
The conference 'Genomics in Society: Facts, Fictions and Cultures' marked the 10th anniversary of the Economic and Social Research Council's Genomics Network, and also the passing of nearly ten years since the completion of the Human Genome Project... [Read More]
12 March 2012 - by Maren Urner 
A single tumour can have many different genetic mutations at various locations, cancer researchers have found. In a study, two thirds of the specific genetic faults identified in tumours were not repeated in the same tumour... [Read More]
16 January 2012 - by Dr Zara Mahmoud 
A US biotechnology firm has unveiled an automated desktop DNA sequencer that can decode the sequence of the human genome in one day for as little as $1,000 (£650). Given its first public viewing at a consumer electronics show in Las Vegas, Life Technologies Corporation's Ion Proton sequencer uses microchips similar to those found in digital cameras... [Read More]

04 April 2011 - by Maren Urner 
Researchers from the Wellcome Trust Sanger Institute have identified three different genetic mutations linked to acute myeloid leukaemia (AML), a cancer that is characterised by a rapid increase in abnormal white blood cells in the bone marrow.... [Read More]
07 March 2011 - by Dr Jay Stone 
Scientists at Queen's University, Belfast, have developed a new targeted gene therapy for the treatment of breast cancer.... [Read More]
14 February 2011 - by Victoria Kay 
A genetic screening test could help doctors to identify men with the most aggressive types of prostate cancer, UK scientists believe. The test could save men with milder forms of the disease from unnecessary surgery and its potentially serious side effects... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust
PET CONFERENCE
COMMERCIALISATION OF LIFE


Lord Robert Winston, Professor of Science and Society at Imperial College London and speaker at the Progress Educational Trust's conference 'The Commercialisation of Life', taking place in central London on Tuesday 2 December

London, 2 December
Click HERE for details

FREE EVENT
HOW SHOULD YOUR DNA BE USED IN THE 100,000 GENOMES PROJECT?


'Genetic Conditions: How Should Your DNA Be Used in the 100,000 Genomes Project?', a FREE public event being organised by the Progress Educational Trust in central London on the evening of Thursday 6 November 2014

London, 6 November
Click HERE for details

Good Fundraising Code

Advertise your products and services HERE - click for further details